We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONDS:NASDAQOndas Inc Analysis

Data as of 2026-04-22 - not real-time

$11.01

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Ondas Inc. is trading at $11.01, well above its DCF‑derived fair value of $2.06, implying a potential downside of roughly 80% and an **overvalued** market price. Technicals show a bullish MACD (line 0.16 above signal ‑0.06) and an RSI of 61, suggesting modest momentum but also proximity to overbought levels; the 20‑day SMA (9.63) sits below the current price while the 200‑day SMA (7.91) remains far lower, indicating a neutral to slightly bullish bias. The stock exhibits extreme volatility (≈80% 30‑day) and a high beta of 2.83, reflecting sensitivity to market swings. Fundamentally, the company posts negative margins (operating ‑63%, profit ‑2.6%) and a trailing EPS of ‑0.62, yet it holds a strong cash position ($572 M) against modest debt ($25 M) and has secured a $50 M tender for border security and a $30 M de‑mining program, alongside an acquisition of World View Enterprises that expands its ISR platform. Analysts have upgraded the rating to **strong‑buy**, citing revenue guidance reset to $375 M and a growing defense contract pipeline.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but price already near resistance
  • High volatility and decreasing volume
  • Recent large contracts boost sentiment but valuation remains stretched

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue guidance reset and new defense contracts
  • Strong cash balance supporting growth initiatives
  • Potential earnings turnaround as operating cash flow improves

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Fundamental profitability still negative
  • Defense sector growth offsets valuation concerns
  • Sustained high beta and volatility keep risk elevated

Key Metrics & Analysis

Financial Health

Revenue Growth629.20%
Profit Margin-260.23%
P/E Ratio-84.7
ROE-52.56%
ROA-5.44%
Debt/Equity5.34
P/B Ratio9.6
Op. Cash Flow$-38746000
Free Cash Flow$12.0M
Industry P/E37.4

Technical Analysis

TrendNeutral
RSI61.0
Support$7.78
Resistance$11.61
MA 20$9.63
MA 50$10.01
MA 200$7.91
MACDBullish
VolumeDecreasing
Fear & Greed Index86.86

Valuation

Fair Value$2.06
Target Price$20.13
Upside/Downside82.87%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.83
Volatility79.74%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.